Systemic therapies for hepatocellular carcinoma

Author： Palmer Daniel H   Hussain Syed A   Johnson Philip J  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.12, 2004-12, pp. : 1555-1568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transarterial therapies for hepatocellular carcinoma

By Sangro Bruno   D'Avola Delia   Iññarrairaegui Mercedes   Prieto Jesus  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1057-1073

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapies in Hepatocellular Carcinoma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 966-974

Bentham Science Publishers

Access to resources Recommend Favorite

Liver-Directed Therapies for Hepatocellular Carcinoma

By Arciero Cletus A.   Sigurdson Elin R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 8, 2006-09 ,pp. : 768-774

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Killer Consequence of Liver Disease: Market Demands New Therapies for Hepatocellular Carcinoma

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 2, 2005-01 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma

By Zhu Andrew X  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 663-672

Informa Healthcare

Access to resources Recommend Favorite